Search

everythinglearnresearchcommunity

for

Search:↓

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

Women with PCOS in Nigeria have higher heart risk markers, needing early heart health checks.

Early balding linked to higher heart disease risk.

Finasteride helps improve hair growth in men with hair loss but may increase the risk of erectile dysfunction.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

A new method uses expert reviews of home videos to objectively assess children's developmental milestones in single-arm trials.

Disrupting natural body clocks increases the risk of developing type 2 diabetes.

NKG2D gene polymorphism doesn't affect SLE risk but may influence symptoms like rash and hair loss.

Scalp cooling reduces chemotherapy-induced hair loss without increasing risk of skin metastases.

Exosomes could potentially enhance tissue repair and regeneration with lower rejection risk and easier production than live cell therapies.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

Minoxidil absorbs poorly through skin, with low risk of side effects at 1-2% concentration.

Metabolic syndrome in kids and teens is linked to obesity and increases diabetes and heart disease risk; early lifestyle changes are crucial for management.

Finasteride may cause breast enlargement, low testosterone a risk factor.

Anthropometric measurements like weight and BMI may help identify alopecia risk groups.

Medical practitioners need to understand basic statistics to properly evaluate clinical trials and avoid unethical designs.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

Baldness may be linked to heart disease, but the evidence isn't strong enough to consider it a major risk factor.

Stem cell therapies show promise for treating various diseases but face challenges in clinical use and require better monitoring techniques.

Intraoperative corticosteroids reduce swelling, and early care lowers folliculitis risk in hair transplant donor sites.

Botulinum neurotoxin A is effective and safe for treating various conditions, but more clinical trials are needed to fully assess its benefits and risks.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

Acne is not a key diagnostic feature for PCOS, postadolescent men with acne may have insulin resistance, melanoma patients often have few moles, tumor size in CSCC indicates higher risk of serious outcomes, and hidradenitis suppurativa is linked to higher risk of heart problems and death.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.